Heart Failure With Normal Ejection Fraction (HFNEF) in Hemodialysed Patients: Beneficial Effect of Ivabradine.
Phase of Trial: Phase IV
Latest Information Update: 10 Aug 2017
At a glance
- Drugs Ivabradine (Primary)
- Indications Heart failure
- Focus Therapeutic Use
- 18 Jan 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 18 Jan 2012 Actual end date (Jan 2012) added as reported by ClinicalTrials.gov.
- 17 Jun 2011 New trial record